Skip to main content
. 2018 Oct 10;17(1):594–602. doi: 10.3892/ol.2018.9564

Figure 1.

Figure 1.

Survival outcomes of patients in the three treatment groups. Kaplan-Meier curves displaying (A) overall survival rates and (B) progression-free survival rates for patients in the S-1, nedaplatin and radiotherapy group (blue), docetaxel, nedaplatin and radiotherapy group (green) and nedaplatin and radiotherapy group (red). Rhombus, censored value.